Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines

Br J Cancer. 1992 Sep;66(3):444-51. doi: 10.1038/bjc.1992.294.

Abstract

The cytotoxic activity profile of an immunotoxin, SWA11-ricin A chain, recognising a cell-surface antigen associated with human small cell lung cancer (SCLC), was examined in detail using a panel of SCLC, non-SCLC and non lung tumour cell lines in tissue culture. SWA11-ricin A chain was potently and selectively active against three SCLC cell lines of both classic and variant morphologies, inhibiting the incorporation of 3H-leucine with an IC50 of 5 x 10(-11) M. At a concentration of 1 x 10(-8) M, the SWA11 immunotoxin could selectively eliminate in excess of 99.9% of clonogenic tumour cells. Intoxication proceeded rapidly following a 4 h lag phase; the initial rate of protein synthesis inhibition occurred with a t50 of 2 h and a t10 of 7 h. The cytotoxic activity of SWA11-ricin A chain was potentiated by 100-fold in the presence of the carboxylic ionophore monensin at 1 x 10(-7) M. Kinetic studies revealed that monensin enhanced the rate of protein synthesis inhibition by two-fold and eliminated the lag phase suggesting a rapid effect on either the rate or route of internalisation. Studies with SWA11 could detect no influence of monensin on the rate of antibody internalisation and a transient delay in the delivery of internalised antibody to lysosomes was observed by immunoelectron microscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / metabolism
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Carcinoma, Small Cell / metabolism
  • Carcinoma, Small Cell / therapy*
  • Drug Synergism
  • Humans
  • Immunotoxins / therapeutic use*
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / therapy*
  • Microscopy, Immunoelectron
  • Monensin / pharmacology
  • Neoplasm Proteins / metabolism
  • Ricin / therapeutic use*
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Immunotoxins
  • Neoplasm Proteins
  • Ricin
  • Monensin